Vimarsana
Biggest News Aggregation in the World

Page 2 - Once Weekly News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Once Weekly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Once Weekly Today - Breaking & Trending Today

Lilly's tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes in SURMOUNT-2 - Vimarsana News

Lilly's tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes in SURMOUNT-2

Published: April 27, 2023

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that tirzepatide (10 mg and 15 mg) achieved superior weight loss compared to placebo at 72...

Source: prnewswire.com
Related Topics:
Puerto RicoUnited StatesJessica ThompsonJoe FletcherJeff EmmickPrnewswire Eli LillyEli LillyExchange CommissionAmerican Diabetes AssociationClinical Development ProgramLilly United StatesScientific SessionsMultiple Endocrine NeoplasiaPrivate Securities Litigation Reform ActUnited States SecuritiesDevelopment ProgramOnce WeeklyEli Lilly And Company
Yale Endocrinology Obesity Medicine: Approaching Obesity as a Complex, Chronic Disease - Vimarsana News

Yale Endocrinology Obesity Medicine: Approaching Obesity as a Complex, Chronic Disease

Published: October 19, 2022

Yale Endocrinology Obesity Medicine is a multidisciplinary program.

Source: yale.edu
Related Topics:
United StatesNorth HavenHoward FormanWendy SilvermanJohn MortonHarlan KrumholzRajita SinhaSilvio InzucchiWajahat MehalAnia JastreboffRobert SherwinBrian WojeckYale School Of MedicineYale Diabetes CenterUniversity Of MarylandYale Weight Loss ProgramFoundations Fund Professor Of PsychiatryYale CenterAmerican Diabetes Association Scientific SessionsYale New Haven HealthChild Study CenterYale Fatty Liver Disease ProgramHealth VeritasScientist Ania JastreboffYale School
Yale Endocrinology Obesity Medicine: Approaching Obesity as a Complex, Chronic Disease - Vimarsana News

Yale Endocrinology Obesity Medicine: Approaching Obesity as a Complex, Chronic Disease

Published: October 17, 2022

Yale Endocrinology Obesity Medicine is a multidisciplinary program.

Source: yale.edu
Related Topics:
United StatesNorth HavenHoward FormanWendy SilvermanJohn MortonHarlan KrumholzRajita SinhaSilvio InzucchiWajahat MehalAnia JastreboffRobert SherwinBrian WojeckYale School Of MedicineYale Diabetes CenterUniversity Of MarylandYale Weight Loss ProgramFoundations Fund Professor Of PsychiatryYale CenterAmerican Diabetes Association Scientific SessionsYale New Haven HealthChild Study CenterYale Fatty Liver Disease ProgramHealth VeritasScientist Ania JastreboffYale School
Lilly receives U.S. FDA Fast Track designation for tirzepatide for the treatment of adults with obesity, or overweight with weight-related comorbidities - Vimarsana News

Lilly receives U.S. FDA Fast Track designation for tirzepatide for the treatment of adults with obesity, or overweight with weight-related comorbidities

Published: October 6, 2022

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the...

Source: prnewswire.com
Related Topics:
Puerto RicoUnited StatesMike MasonJoe FletcherAnne GillEli LillyDrug AdministrationClinical Development ProgramLilly United StatesExchange CommissionFast TrackMultiple Endocrine NeoplasiaPrivate Securities Litigation Reform ActUnited States SecuritiesOnce WeeklyDevelopment ProgramEli Lilly And Company
Obesity drug halves risk of type 2 diabetes in clinical trial - Vimarsana News

Obesity drug halves risk of type 2 diabetes in clinical trial

Published: September 22, 2022

This could revolutionize how we treat weight issues in patients who cannot exercise due to health concerns.

Source: zmescience.com
Related Topics:
United StatesDrug Administration OnDrug AdministrationMyriam ZillesOnce WeeklyNew England Journal